These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4614114)

  • 1. [Use of a new drug in the treatment of gastroduodenal diseases].
    Bagliani A; Borri P
    Minerva Gastroenterol; 1972; 18(3):165-74. PubMed ID: 4614114
    [No Abstract]   [Full Text] [Related]  

  • 2. [Zolimidine. Evaluation of the symptomatic effect in patients with gastroduodenal diseases].
    Rizzi B; Giacomini F; Bandini V
    Minerva Gastroenterol; 1975; 21(4):258-65. PubMed ID: 778658
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect, on gastric absorption, of a new molecule with mucopoietic activity, 2-)p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine, used in therapy of gastroduodenal diseases].
    Barlattani M
    Clin Ter; 1971 Dec; 59(5):417-30. PubMed ID: 5159600
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastro-protective drug, zolimidine.
    Camarri E; Zaccherotti L; D'Alonzo D
    Arzneimittelforschung; 1972 Apr; 22(4):768-72. PubMed ID: 5068258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of a new synthetic preparation (zolimidine) in the treatment of gastroduodenal diseases].
    Rivero Fontán JL; Barranco Jiménez M; Gómez Parra M
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):103-26. PubMed ID: 5069487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study on 20 gastroduodenal ulcer patients treated with 2-p-methyl sulphonylphenyl imidazol (1,2-alpha) pyridine (zolimidine)].
    García Alvarez M; Ramírez Armengol JA
    Rev Clin Esp; 1972 Aug; 126(4):353-6. PubMed ID: 4638610
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind study of proglumide, zolimidine and carbenoxolone in peptic ulcer and gastroduodenitis].
    Corazza GR; D'Ambro A; Grimoldi D
    Minerva Dietol Gastroenterol; 1979; 25(1):47-58. PubMed ID: 156316
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment with phentonium in some gastric and duodenal diseases].
    Ramasso M; Ciancamerla G; Massaro A
    Minerva Gastroenterol; 1972; 18(4):236-40. PubMed ID: 4614119
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results obtained with Dogmagel in the treatment of gastroduodenal ulcer and gastroduodenitis].
    Sánchez García-Moreno I
    Rev Esp Enferm Apar Dig; 1974 Dec; 44(7):743-6. PubMed ID: 4445556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutical prospects of a piperonylpiperazine derivative (Pifarnine) in gastroduodenal diseases in the aged].
    Porro A; Magnani P; Battaglia A
    Farmaco Prat; 1979 Feb; 34(2):85-92. PubMed ID: 378690
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gastroduodenal diseases associated with helicobacter pylori].
    Grigor'ev PIa; Iakovenko EP
    Klin Med (Mosk); 1998; 76(6):11-5. PubMed ID: 9693493
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of gastroduodenal diseases with a new drug combination].
    Maiorano G; Dell'Aera P; Vitale A; Guida V
    Minerva Gastroenterol; 1970; 16(4):181-90. PubMed ID: 5516915
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on a new protective agent of gastro-duodenal mucous membrane].
    Sardet MB; Ruas J
    J Med Bord; 1967 Aug; 144(8):1188-97. PubMed ID: 5619385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statistical study on the treatment of gastro-duodenal ulcer, gastritis and painful gastro-esophagic syndromes].
    Gerolami A; Deck M; Camatte R; Sarles H
    Therapeutique; 1969 Nov; 45(9):907-10. PubMed ID: 4903936
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of zolimidine, a derivative of imidazo (1,2-a) pyridine, on the gastric mucosa of patients with gastric disorders.
    Celli L; Clementi F; Santagostino C
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):105-23. PubMed ID: 809228
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and secretory studies with a new anatacid].
    Goethals C; Vantrappen G
    Tijdschr Gastroenterol; 1967; 10(1):77-84. PubMed ID: 5343052
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of a new preparation with anti-inflammatory, analgesic and antipyretic activity. Crossed double-blind study of cases according to a sequential plan].
    Landerghini V; Quaglia G
    Clin Ter; 1975 Jun; 73(6):533-60. PubMed ID: 1139868
    [No Abstract]   [Full Text] [Related]  

  • 18. [Personal experience in the treatment of stomach diseases (peptic ulcer and gastroduodenitis) with a synthesis of metachlopramide and beta-glycirrhetic acid].
    Lopez-Calderon Barreda ; Barado Sanchez F; Garcia Perez M
    Rev Esp Enferm Apar Dig; 1970 Dec; 32(7):783-94. PubMed ID: 5503933
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C
    Clin Ter; 1979 Mar; 88(6):605-19. PubMed ID: 157245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic efficacy of trithiozine (ISF 2001) in gastroduodenal diseases].
    Barbara L; Corinaldesi R; Miglioli M; Guidoboni R; Luchetta L; Lami F; Labó G
    Minerva Gastroenterol; 1975; 21(4):169-83. PubMed ID: 778657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.